FDA investigators audited the Allergan Sales - Waco, TX, United States facility and issued inspectional observations (via FDA 483) on 14 May 2003.
Product details
- Category: Human Drugs / Medical Devices & Rad Health
- Inspection end: 14 May 2003
- Location: Waco, United States
- FEI: 1643525
